Spyglass Pharma, Inc. reports a Return on Equity (ROE) of -17.43%.

What is SGP's dividend yield?

Spyglass Pharma, Inc. offers a dividend yield of 0.00%.

What is SGP's Quality Score?

Our AI rates SGP's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy SGP?

Our AI Timing Score for SGP is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does SGP belong to?

Spyglass Pharma, Inc. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Spyglass Pharma, Inc. (SGP) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

SGP AI Analysis Summary

Our AI summary for SGP: Spyglass Pharma, Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -17.43%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SGP

Spyglass Pharma, Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 24.11

1.43 (6.31%) Day Change

Watchlist Portfolio Compare Chart

0.03

D/E

-17.4%

ROE

-16.9%

ROA

0.00%

Div Yield

SPYGLASS PHARMA, INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 24.11 Price 1.43 (6.31%) Day Change	NEWS SCORE: 98

SGP, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	425
Magic Formula Rank by ROE	425
Magic Formula Rank by ROIC	379
Price	24.11
PBV / Sector	3.03 / 44,022.72
Earning Per Share	-1.39

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	2.41 M GREAT
Average 1W Daily Value	2.09 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.24
NPM Average (%) / Sector	N/A / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-16.87 / 185,260.96
ROA Average (%) / Sector	-52.18 / 36,684.70
ROA Change Average (%) / Sector	54.32 / 422,221.66 GREAT
ROE (%) / Sector	-17.43 / 243,762.23
ROE Average (%) / Sector	27.88 / 48,758.47 GREAT
ROE Change Average (%) / Sector	-46.71 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:50
Symbol	SGP
Name	SPYGLASS PHARMA, INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	33.43 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	758.27 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 27061 Aliso Creek Road, Aliso Viejo, CA, United States, 92656

Phone: 949 284 6904

Website: https://www.spyglasspharma.com

Employees: 68

Sector: Healthcare >> Biotechnology

Description: SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California.